ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market. To ...
Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to ...
Full-year 2025 preliminary1 U.S. net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) total injection demand grew 17% ...
In the regulated pharmaceutical sector, maintaining awareness and connectivity is vital. Industry professionals attend ...
The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...
Novo Nordisk faces GLP-1 headwinds after the FDA-approved Wegovy pill, and LLY gains share, margins erode, and the pipeline ...
In coming weeks, Wegovy pill will be available in four doses: a starter dose of 1.5 mg, as well as 4 mg, 9 mg, and 25 mg. As ...
In a remarkable pivot, Athira Pharma is shifting its primary focus from Alzheimer’s to oncology following a multi-year period marked by clinical failures and leadership turnover. The Bothell, ...
Shares of Piramal Pharma are set to be in focus on Friday, December 12 after the US Food and Drug Administration concluded a general Good Manufacturing Practices inspection at the company’s Lexington ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback